Archives

by in
Entry Author Date Location
Epizyme Buys Back Control of Cancer Drug From Eisai For up to $110M 03/12/15 Boston
Apple: A123’s Lawsuit “Baseless Conjecture,” Not Actionable Under Law 03/11/15 Boston
Ocular’s Long-Lasting Eye Drug Tech Passes First Late-Stage Test 03/10/15 Boston
Early VC Arch Exits Ikaria with $2.3B Sale to Mallinckrodt 03/05/15 New York
Just Eight Days Left—Get Your Seat for “New York’s Life Science Disruptors” 03/04/15 New York
Bellicum CEO Reflects on Rise From Baylor to Houston Biotech Darling 02/26/15 Texas
West Coast Biotech Roundup: Flexus, NGM, Illumina, Bob Klein & More 02/26/15 San Francisco
East Coast Biotech Roundup: Vertex, Syndax, Build-to-Buy Deals & More 02/20/15 Boston
West Coast Biotech Roundup: Laguna, SeaGen, Unchained, DME & More 02/19/15 San Francisco
Fears Percolate as Billion-Dollar Private Company Valuations Climb 02/19/15 National
Syndax CEO Says an Immuno-Oncology Thing Happened on the Way to IPO 02/17/15 Boston
West Coast Biotech Roundup: Dendreon, Invitae, Juno, Regulus & More 02/12/15 Seattle
Aiming for One-Stop Diagnostic Tests, Invitae Raises $102M in IPO 02/12/15 San Francisco
Cardio Study Gives Life To Armetheon’s Blood-Thinning Drug 02/09/15 San Francisco
West Coast Biotech Roundup: Tracon, Mirati, Third Rock, & Dendreon 02/06/15 San Diego
Investors Line up For Westphal as Muscle Cramp Startup Upsizes IPO 01/28/15 Boston
From Yeast, Yumanity Looks to Give Rise to Critical Neuro Drugs 01/26/15 Boston
As Box IPOs, a Competitor Previews the Market Share Battle 01/23/15 San Francisco
East Coast Biotech Roundup: Alnylam, Stock Offerings, Curis, & More 01/23/15 Boston
In the Jiu-Jitsu Match of Biotech Risk, a Reminder of Other Paths 01/20/15 National
J.P. Morgan 2015: Notes, Thoughts, And Conversations From the Vortex 01/16/15 National
Box Steps Back Onto IPO Runway 01/09/15 San Francisco
East Coast Biotech Roundup: Pre-J.P. Morgan Preening Edition 01/09/15 Boston
One Week Into The New Year, Five Biotechs Reel in $220M Venture Cash 01/08/15 National
Startup 101: Texas Venture Labs Pairs UT Students With Entrepreneurs 01/07/15 Texas
Don’t Get Comfortable: 5 Biopharma Flashpoints to Consider in 2015 01/06/15 National
With Massive Venture Round, Moderna Has $450M Reasons to Stay Private 01/05/15 Boston
Larry Corey, Cofounder of 2014 Top Biotech Juno: “It’s No Outlier” 01/05/15 Seattle
Texas’s Innovative 2014: IPOs, Startup Funding Programs & SXSW 12/31/14 Texas
West Coast Biotech Roundup: Gilead/AbbVie, Juno, Auspex, Bina & More 12/23/14 San Francisco
Page 2 of 15 « previous page · next page »